Other Open Access
Lupinacci, Lisa; Railkhar, Radha
2003_FDA_r_s_DAP-Gardasil-HPV-013.pdf
Statistical Data Analysis Plan HPV Quadrivalent HPV Vaccine CIN/Wart Efficacy Study (Study 013) March 2003
2003_FDA_r_s_DAP-Gardasil-HPV-015.pdf
Statistical Data Analysis Plan HPV Quadrivalent HPV Vaccine, Safety, Immunogenicity and Efficacy Study (Study 015) FUTURE II - July 2003
We obtained Gardasil® Data Analysis Plans (DAPs) from the FDA through Freedom of Information Act (FOIA) request. The above linked DAPs specified a “per protocol analysis” for the outcome CIN 2+ irrespective of HPV type.
Name | Size | |
---|---|---|
2003_FDA_r_s_DAP-Gardasil-HPV-013.pdf
md5:05c48505dce234778e2c5aa9f1e8b3e0 |
2.7 MB | Download |
2003_FDA_r_s_DAP-Gardasil-HPV-015.pdf
md5:c9500e80ede7382540f187fc65f24ad9 |
3.5 MB | Download |
All versions | This version | |
---|---|---|
Views | 2,303 | 2,302 |
Downloads | 339 | 339 |
Data volume | 984.3 MB | 984.3 MB |
Unique views | 2,226 | 2,225 |
Unique downloads | 264 | 264 |